3rd Quarter - Report

BELL & LINDSAY, INC. (FORMERLY WHITE HOUSE CONSULTING INC.) for OYE THEREPEUTICS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General Consulting and informing federal agencies and Congress on the research that OYE Therapeutics is currently doing.

LobbyistCovered position, as disclosed
MARK F LINDSAY US House Staff

Contacted: Office of Natl Drug Control Policy (NDCP); Executive Office of the President (EOP); SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.